01918nas a2200253   4500000000100000008004100001260005500042653002300097653002100120653002900141653003000170653001500200653001000215653001200225100001500237700001700252700001200269700001600281245017000297856014200467300000800609520102200617022002501639       2025                            d  c12/2025bOvid Technologies (Wolters Kluwer Health)10aConstruct Validity10acontent validity10aQuestionnaire validation10aquestionnaire development10aValidation10aIndia10aleprosy1 aKomrraju S1 aSathyanath D1 aKumar N1 aShrikanth M00aDevelopment and Validation of a Questionnaire to Assess Social Perspectives Among Leprosy-Affected Individuals in a Rehabilitation Colony in Pune, Maharashtra, India  uhttps://deleprastichting-my.sharepoint.com/:b:/g/personal/e_williams_infontd_org/IQBvX0WYEVdOTZm_CKr2iE2rAUcEs8wNvc314gLp5ZnisGU?e=DxLeNf  a1-33 a<p><strong>Background: </strong></p>

<p>Leprosy persists as a social and health issue in India, requiring validated tools to evaluate perspectives on stigma, knowledge, and needs. This study developed and validated a questionnaire with domains: sociodemographics, living conditions, health status and practices, knowledge about leprosy, and felt needs and priorities.</p>

<p><strong>Methods:</strong></p>

<p>Cross-sectional validation with 138 participants from Antulay Nagar, Pune, January–June 2024. Content validity via expert panel (I-CVI, S-CVI/Ave). Construct validity using EFA (KMO = 0.82, Bartlett’s χ² = 1265.4, P &lt; 0.001). Reliability with Cronbach’s alpha.</p>

<p><strong>Results:</strong></p>

<p>I-CVI 0.75–1.00, S-CVI/Ave 0.90; three items revised. Five factors emerged with loadings &gt;0.60. Cronbach’s alpha 0.79–0.88.</p>

<p><strong>Conclusion:</strong></p>

<p>The questionnaire is valid and reliable for assessing social perspectives in leprosy settings.</p>
  a0976-4879, 0975-7406